警惕!阳后罹患心血管疾病风险大幅上升,干细胞疗法有效修复心肌损伤
[2]Wan EYF,Mathur S,Zhang R,Yan VKC,Lai FTT,Chui CSL,Li X,Wong CKH, Chan EWY,Yiu KH,Wong ICK. Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank. Cardiovasc Res. 2023 Jan 19:cvac195. doi: 10.1093/cvr/cvac195. Epub ahead of print. PMID: 36652991.
[3]谭明亮,刘雅,程伟等. 2019新型冠状病毒感染所致心肌损害及防治策略[J]. 中国动脉硬化杂志, 2020, 28(4):296-300.
[4]Leng ZK,Zhu RJ,Hou W,et al. Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia[OL]. China Xiv ( 2020-02-28) .[2020-03-06]. http: / / chinaxiv.org /abs /202002.00080.
[5]https://www.sciencedirect.com/science/article/abs/pii/S0024320520303301
[6]中国医师协会心血管内科医师分会. 新型冠状病毒感染与心血管疾病诊疗中国专家共识(2023)[J/OL]. 中华心血管病杂志(网络版),2023,6:e1000136(20230118).http://www.cvjc.org.cn/index.php/Column/columncon/article_id/314. DOI:10.3760/cma.j.cn116031.2023.1000136.
本文由湖南云上细胞科技有限公司发布,部分素材来源网络,如有侵权请联系我们删除,转载联系作者并注明出处:http://www.xbgtt.com/zaishengyixue/2064.html